Globeflex Capital L P Buys 6,304 Shares of ICU Medical, Incorporated (ICUI)

Globeflex Capital L P lifted its stake in ICU Medical, Incorporated (NASDAQ:ICUI) by 133.9% in the third quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 11,011 shares of the medical instruments supplier’s stock after purchasing an additional 6,304 shares during the quarter. ICU Medical comprises 0.6% of Globeflex Capital L P’s portfolio, making the stock its 21st biggest holding. Globeflex Capital L P’s holdings in ICU Medical were worth $3,113,000 as of its most recent filing with the SEC.

Several other institutional investors also recently made changes to their positions in ICUI. American International Group Inc. increased its holdings in shares of ICU Medical by 9.8% in the 3rd quarter. American International Group Inc. now owns 33,778 shares of the medical instruments supplier’s stock valued at $9,551,000 after acquiring an additional 3,017 shares during the period. BlackRock Inc. grew its stake in ICU Medical by 8.3% during the 3rd quarter. BlackRock Inc. now owns 1,431,253 shares of the medical instruments supplier’s stock worth $404,685,000 after buying an additional 109,396 shares during the last quarter. Martingale Asset Management L P grew its stake in ICU Medical by 452.0% during the 3rd quarter. Martingale Asset Management L P now owns 137,485 shares of the medical instruments supplier’s stock worth $38,875,000 after buying an additional 112,577 shares during the last quarter. Bank of New York Mellon Corp grew its stake in ICU Medical by 10.6% during the 3rd quarter. Bank of New York Mellon Corp now owns 191,956 shares of the medical instruments supplier’s stock worth $54,275,000 after buying an additional 18,465 shares during the last quarter. Finally, Janus Henderson Group PLC grew its stake in ICU Medical by 0.5% during the 3rd quarter. Janus Henderson Group PLC now owns 1,370,845 shares of the medical instruments supplier’s stock worth $387,606,000 after buying an additional 7,475 shares during the last quarter. Hedge funds and other institutional investors own 74.49% of the company’s stock.

Several brokerages recently weighed in on ICUI. Zacks Investment Research upgraded ICU Medical from a “hold” rating to a “strong-buy” rating and set a $297.00 target price on the stock in a research note on Thursday, November 1st. ValuEngine downgraded ICU Medical from a “buy” rating to a “hold” rating in a research note on Tuesday, November 6th. BidaskClub downgraded ICU Medical from a “buy” rating to a “hold” rating in a research note on Thursday, November 8th. Finally, TheStreet upgraded ICU Medical from a “c+” rating to a “b+” rating in a research note on Monday, August 20th.

Shares of ICUI stock opened at $233.17 on Wednesday. ICU Medical, Incorporated has a 1-year low of $201.65 and a 1-year high of $321.70. The firm has a market cap of $4.84 billion, a P/E ratio of 42.24 and a beta of 0.65.

ICU Medical (NASDAQ:ICUI) last announced its earnings results on Thursday, November 8th. The medical instruments supplier reported $1.85 earnings per share for the quarter, topping the Thomson Reuters’ consensus estimate of $1.51 by $0.34. ICU Medical had a return on equity of 15.20% and a net margin of 6.00%. The firm had revenue of $327.20 million for the quarter, compared to the consensus estimate of $334.97 million. During the same period in the previous year, the business earned $1.12 EPS. The firm’s revenue for the quarter was down 4.7% on a year-over-year basis. As a group, analysts predict that ICU Medical, Incorporated will post 7.76 earnings per share for the current year.

In other ICU Medical news, VP Virginia Ruth Sanzone sold 787 shares of the business’s stock in a transaction dated Tuesday, August 28th. The stock was sold at an average price of $303.12, for a total transaction of $238,555.44. Following the sale, the vice president now owns 1,367 shares in the company, valued at approximately $414,365.04. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, Director Pfizer Inc sold 2,500,000 shares of the business’s stock in a transaction dated Thursday, November 15th. The shares were sold at an average price of $209.25, for a total value of $523,125,000.00. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 2,511,920 shares of company stock worth $526,731,956. 12.50% of the stock is owned by company insiders.

COPYRIGHT VIOLATION NOTICE: “Globeflex Capital L P Buys 6,304 Shares of ICU Medical, Incorporated (ICUI)” was originally published by Markets Daily and is owned by of Markets Daily. If you are accessing this report on another publication, it was illegally stolen and republished in violation of United States and international trademark and copyright legislation. The correct version of this report can be viewed at https://www.themarketsdaily.com/2018/11/21/globeflex-capital-l-p-buys-6304-shares-of-icu-medical-incorporated-icui.html.

ICU Medical Profile

ICU Medical, Inc develops, manufactures, and sells medical devices used in vascular therapy, critical care, and oncology applications worldwide. It offers infusion therapy products comprising a tube running from a bottle or plastic bag containing a solution to a catheter inserted in a patient's vein.

Further Reading: How can you know how many shares are floating?

Want to see what other hedge funds are holding ICUI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for ICU Medical, Incorporated (NASDAQ:ICUI).

Institutional Ownership by Quarter for ICU Medical (NASDAQ:ICUI)

Receive News & Ratings for ICU Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ICU Medical and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply